MedTrace Logo

Acute Physiological Effects of Full-Body Far-Infrared Emitting Textiles on Young Road Cyclists

NCT07503977 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2026-03-31

No results posted yet for this study

Summary

Road cycling is a sport characterized by long, high-intensity training sessions. Cyclists train and compete in varying temperatures, which can affect their performance. Therefore, thermoregulation is a fundamental capacity in endurance sports such as cycling. Far-infrared (FIR) emitting fibers have recently been used in garments during and after exercise to modulate thermoregulation and enhance muscle recovery. Every competitive cyclist voluntarily underwent testing at a temperature-controlled laboratory after reading and signing the informed consent document. Participants were invited to three separate sessions at the laboratory. During the first session, essential personal information (name, surname, sex, age, height and weight) was recorded. In addition, an incremental test was performed on a cycle ergometer to measure VO2Max and ventilatory threshold 1 (VT1). Subsequently, they were randomly divided into two conditions: an experimental garment (EG) with FIR and a control garment (CG). Each test session consisted of 40 minutes at VT1, followed by a 5-second sprint at the end. During the test, various physiological parameters were assessed: Oxygen consumption (VO2), heart rate (HR), blood lactate, body temperature (skin and core temperature), and sensations of exertion and sweating.

Conditions

  • Athletes
  • Cyclists

Interventions

DEVICE

FIR

FIR is a passive emitter composed of textile fibers integrated with bioceramics and light-emitting minerals.

DEVICE

Placebo

a similar-looking suit but without FIR

Sponsors & Collaborators

  • University of Urbino "Carlo Bo"

    collaborator OTHER

  • University of Palermo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2025-06-25
Completion
2025-06-25

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07503977 on ClinicalTrials.gov